Vivian Karla Brognoli Franco
Research Subjects
Vivian Karla Brognoli Franco has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Gonçalves de Oliveira
Fundação Hemominas, Belo Horizonte, Brazil
3 shared publications - Claudia Santos Lorenzato
Centro de Hematologia e Hemoterapia do Paraná (HEMEPAR) Curitiba Brazil
3 shared publications - Maíse Moreira Dias
Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
3 shared publications - Ricardo Mesquita Camelo
Universidade Federal de Minas Gerais
3 shared publications - Rosângela de Albuquerque Ribeiro
Centro de Hematologia e Hemoterapia do Ceará (HEMOCE), Fortaleza, Brazil
3 shared publications - Suely Meireles Rezende
Department of Internal Medicine, Faculty of Medicine Universidade Federal de Minas Gerais Belo Horizonte Minas Gerais Brazil
3 shared publications
Latest Publications
- 1 May 2025
- Published by Elsevier in Thrombosis Research
- Vol. 250, 109336
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study
- 1 May 2025
- Published by Elsevier in Thrombosis Research
- Vol. 250, 109336
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 143 (4) , e2023359
HFE mutations in patients with iron overload in Santa Catarina: a cross-sectional study
BACKGROUND: Investigating the frequency and characteristics of iron overload cases with HFE gene mutation is crucial, given the population-level risks associated with excessive iron.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 143 (4) , e2023359
Open AccessHFE mutations in patients with iron overload in Santa Catarina: a cross-sectional study
BACKGROUND: Investigating the frequency and characteristics of iron overload cases with HFE gene mutation is crucial, given the population-level risks associated with excessive iron.
- 24 February 2023
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 41 (1) , 74-80
Changing recombinant factor VIII to plasma-derived factor VIII during immune tolerance induction
Hemophilia A (HA) is a hereditary X-linked bleeding disorder, characterized by the deficiency of the clotting factor VIII (FVIII) due to mutations in its coding gene (F8).1 Breakthrough bleedings, ...
- 24 February 2023
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 41 (1) , 74-80
Changing recombinant factor VIII to plasma-derived factor VIII during immune tolerance induction
Hemophilia A (HA) is a hereditary X-linked bleeding disorder, characterized by the deficiency of the clotting factor VIII (FVIII) due to mutations in its coding gene (F8).1 Breakthrough bleedings, ...
- 14 September 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (11) , 2526-2537
Time between inhibitor detection and start of immune tolerance induction: Association with outcome in the BrazIT study
- 14 September 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (11) , 2526-2537
Time between inhibitor detection and start of immune tolerance induction: Association with outcome in the BrazIT study